Biosplice Therapeutics IPO

Biosplice Therapeutics is developing therapies through alternative pre-mRNA splicing, which can allow for the elimination of harmful proteins. The company's current pipeline focuses on osteoarthritis and oncology. Biosplice Therapeutics was founded in 2008 by Osman Kibar Ph.D., Dennis Carson, Richard Schwab, and John Hood Ph.D. and is headquartered in San Diego, CA.

Register for Details

For more details on financing and valuation for Biosplice Therapeutics, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

What is Biosplice Therapeutics's ticker symbol?

Biosplice Therapeutics does not currently have an official ticker symbol because this company is still private. Register today to connect with our Private Market Specialists and learn more about new pre-IPO investment opportunities.

What is Biosplice Therapeutics's stock price?

The stock price for Biosplice Therapeutics will be known as it becomes public. Here are similar public companies: HealthStream (NAS: HSTM), Doximity (NYS: DOCS), Zymergen (NAS: ZY), Sight Sciences (NAS: SGHT).

Who are Biosplice Therapeutics's major investors?

Vickers Venture Partners
Vast Ventures
Forepoint Capital Partners
Polar Light Ventures
aMoon Fund
SymBiosis Capital Management

Learn more about Biosplice Therapeutics

Forge green plus iconForge green minus icon

When was Biosplice Therapeutics founded?

Biosplice Therapeutics was founded in 2008.
Forge green plus iconForge green minus icon

Can you invest in Biosplice Therapeutics?

Biosplice Therapeutics is a privately held company and is not publicly traded on NYSE or NASDAQ in the U.S. To buy pre-IPO shares of a private company, you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.

Forge green plus iconForge green minus icon

Can you sell Biosplice Therapeutics share pre-IPO?

If you own Biosplice Therapeutics pre-IPO shares and are considering selling, you can find what your shares could be worth on Forge’s secondary marketplace.

Our Private Market Specialists are available to answer any questions you might have and can help connect you with a buyer from our network of 125,000 accredited investors and institutions. You can also learn more about how to sell your private shares before getting started.

Forge green plus iconForge green minus icon

Is Biosplice Therapeutics a publicly traded company?

Biosplice Therapeutics is a private company and not publicly traded.

If you are interested in buying or selling private company shares, you can register with Forge today for free to explore your options. Registering gives you access to one of our Private Market Specialists who can guide you through the process of buying or selling. Learn more about how Forge might help you buy pre-IPO shares or sell pre-IPO shares.

Updated on: Nov 15, 2023

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.